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pH sensitivityIn this work, we sought to rationally design membrane-active peptides that are triggered by low pH to form
macromolecular-sized pores in lipid bilayers. Such peptides could have broad utility in biotechnology and in
nanomedicine as cancer therapeutics or drug delivery vehicles that promote release of macromolecules from
endosomes. Our approach to rational design was to combine the properties of a pH-independent peptide,
MelP5, which forms large pores allowing passage of macromolecules, with the properties of two pH-
dependent membrane-active peptides, pHlip and GALA. We created two hybrid sequences, MelP5_Δ4 and
MelP5_Δ6, by using the distribution of acidic residues on pHlip and GALA as a guide to insert acidic amino
acids into the amphipathic helix of MelP5.We show that the new peptides bind to lipid bilayers and acquire sec-
ondary structure in a pH-dependent manner. The peptides also destabilize bilayers in a pH-dependent manner,
such that lipid vesicles release the smallmolecules ANTS/DPX at low pHonly. Thus, wewere successful in design-
ing pH-triggered pore-forming peptides. However, no macromolecular release was observed under any condi-
tions. Therefore, we abolished the unique macromolecular poration properties of MelP5 by introducing pH
sensitivity into its sequence. We conclude that the properties of pHlip, GALA, and MelP5 are additive, but only
partially so.We propose that this lack of additivity is a limitation in the rational design of novelmembrane-active
peptides, and that high-throughput approaches to discovery will be critical for continued progress in the ﬁeld.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Many potential applications of membrane-active peptides have
been discussed in the literature [1–8]. Yet their utility has been limited,
partly becausemany such peptides come from natural sources and have
not been engineeredwith particular applications in mind [9,10]. We re-
cently embarked on a project to synthetically evolve a potent pore-
forming peptide [11]. We reported that an analog of the bee venom
lytic peptide melittin, MelP5, possesses the unique ability to assemble
into macromolecule-sized, equilibrium pores under conditions where
naturalmembrane-active sequences are inactive [12]. Unlike the parent
peptide melittin, which forms small, transient pores under most condi-
tions [1,13,14], MelP5 forms pores that persist for hours and allow the
passage of macromolecules across bilayers, including dextrans
(10 kDa) and chymotrypsin (24 kDa), even at very low peptide concen-
trations [11,12].
A question arises if MelP5 can be engineered such that its unique
macromolecular poration activity can be controlled by pH. Of particular
interestwould be the design of a peptide that is notmembrane active at
pH 7 but interacts with membranes and forms macromolecule-sized), kh@jhu.edu (K. Hristova).equilibriumpores at lowpH. A peptidewith this propertywould be use-
ful for multiple biomedical applications. For example, it would be useful
in the generic delivery of macromolecules into cells via endocytosis
where endosomal acidiﬁcation would lead to release of endocytosed
macromolecular cargo into the cytosol. pH-sensitive membrane-active
peptides could also be targeted to tumor cells,wheremembrane perme-
abilizationwould be triggered by the decreased pH that occurs in the vi-
cinity of solid tumors [15]. While a peptide that forms macromolecular
pores with pH-sensitive activity currently does not exist, there are
known membrane-active peptides with pH-sensitive membrane bind-
ing, insertion, and permeabilization that guided the work described
here. One such peptide, called pHLIP, is a monomeric random coil at
neutral pH but inserts into membranes as a monomeric, membrane-
spanning α-helix upon acidiﬁcation, with an apparent pKa of ~6.0 [16,
17]. pHLIP does not cause membrane permeabilization. A composition-
ally similar peptide, called GALA, is likewise a random coil at neutral pH
but assembles into highly active, but small, membrane-spanning pores
with an apparent pKa of ~5.5 [18,19].
Each of these pH-sensitive, membrane-active peptides has acidic
glutamate and aspartate residues interspersed into an otherwise hydro-
phobic sequence (Fig. 1). Each folds into anα-helix inmembraneswhen
partitioning and folding become favorable at low pH. Similarly, MelP5
folds into an amphipathic helix when bound to membranes, although
Fig. 1.Helical wheel projection diagrams of GALA, pHLIP, MelP5, MelP5_Δ4, and MelP5_Δ6. Residues colored blue are hydrophobic, yellow are hydrophilic, red are anionic at neutral pH,
and purple are cationic at neutral and low pH. Below are the sequences of the ﬁve peptides. The red letters signify the acidic residues in GALA and pHlip, and the acidic residues inserted
into the sequence of MelP5 to make MelP5_Δ4 (4 substitutions) and MelP5_Δ6 (6 substitutions).
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designing pH-sensitive macromolecular pore-forming peptides, we
sought to combine the macromolecular pore formation of MelP5
with the pH-sensitive membrane activity of pHLIP and GALA. Here
we report on the rational design of two such peptides and on the
investigation of their membrane activities over a pH range between
3 and 7.
2. Materials and Method
2.1. Reagents
1-Palmitoyl-2-oleoly-sn-3-glycero-phosphocholine (POPC) was
purchased from Avanti Polar lipids as a lyophilized powder and dis-
solved in chloroform at 25 mg/ml for use. MelP5, MelP5_Δ4, and
MelP5_Δ6 were synthesized by Biosynthesis, Inc. and were solubilized
in methanol. Melittin was purchased as a lyophilized powder fromSigma-Aldrich and dissolved in methanol. Biotin-dextran-(10kD)-
TAMRA and Avidin-Alexaﬂuor488 were purchased from Invitrogen. All
other reagents were purchased from Sigma-Aldrich.2.2. Buffer Preparation
All buffers were made using millipore puriﬁed water. Sodium phos-
phate buffers were prepared at 10 mM with or without 100 mM
potassium chloride at either pH 6 and pH 7. Sodium acetate buffers
were prepared at 10 mM with or without 100 mM potassium chloride
at pH 5, pH 4.5, pH 4, pH 3.5, and pH 3. Buffer for the ANTS/DPX
experiment was made by adding 12.5 mM ANTS, 45 mM DPX, 5 mM
HEPES, and 20 mM potassium chloride. Buffer for the FRET-leakage
assay was made by adding 1 mg/ml of biotin-dextran (10kD)-TAMRA
to either pH 7 sodium phosphate buffer or pH 4 sodium acetate buffer
described above.
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POPC vesicles were prepared by standard methods [20,21]. Lipids in
chloroform were dispensed into glass vials using glass syringes, dried
under nitrogen for at least 15 min, and then dried completely under
high vacuum for at least 3 h. After drying, lipids were resuspended in
buffer. The suspension was subjected to 10 cycles of freezing in liquid
nitrogen followed by thawing in a bath of room temperature water,
and then the suspension was extruded 10 times through 0.1 μm pore
Nuclepore polycarbonate ﬁlters. The lipid concentration was then mea-
sured using a modiﬁed version of the Stewart assay [22].
2.4. Binding assay
Binding assays were performed with ﬂuorescence titration [23]
using 10 μM peptide solution in one of the pH buffers and titrating up
to 10 mM lipid. Intensities at 335 nmwere obtained for each lipid con-
centration and normalized to the intensity measured in the absence of
lipid. To enable correction for vesicle-dependent light scattering effects,
as described elsewhere [23], we alsomeasured the normalized intensity
of 10 μM free tryptophan (which does not bind to bilayers) at 335 nmat
the same lipid concentrations. To obtain values for the mole fraction
partition coefﬁcient (Kx), the normalized and corrected intensity data
were ﬁt to the following equation:
I Lð Þ ¼ 1þ I∞−1ð Þ
Kx  L
55:3þ Kx  L
ð1Þ
where I(L) is the normalized, corrected ﬂuorescence at lipid concentra-
tion L, I∞− 1 is themaximum ﬂuorescence enhancement, and 55.3 M is
the molar concentration of water. Partition coefﬁcients, Kx, were con-
verted to free energies using the Gibbs equation:
ΔG ¼−RT ln Kxð Þ ð2Þ
2.5. Circular dichroism spectroscopy
Samples for circular dichroism (CD) spectroscopy were prepared by
diluting the peptides from methanol into sodium phosphate or sodium
acetate buffers without potassium chloride at various pH values to a
ﬁnal peptide concentration of 100 μM. After the ellipticitywas recorded,
vesicles were added to a ﬁnal concentration of 1 mM, and the ellipticity
was recorded again. These data were collected with a scanning rate of
0.5 nm/s.
2.6. ANTS/DPX, small molecule leakage assay
To test for small pores in synthetic bilayers, vesicles were prepared
with encapsulated ANTS/DPX solution at either pH 4 or pH 7. These ves-
icle solutions were diluted to 1 mM lipid concentration for leakage ex-
periments. The samples were excited at 360 nm, and the emission was
collected at 530 nm over a period of about 200–300 s. After about
50 s, varying amounts of the peptides were added to the solution. The
emission intensity was recorded for up to 150 s at which time 10 μL of
10% Triton X-100 was added to lyse the vesicles. Fractional leakage
from the vesicles was calculated using the following equation:
Fractional leakage ¼ Ipeptide−Ibackground
Ifinal−Ibackground
ð3Þ
where Ipeptide is the signal after adding the peptide, Iﬁnal is the signal
after adding Triton X-100, and Ibackground is the signal without adding
anything extra to the solution.2.7. FRET-based, large molecule leakage assay
Large molecule leakage was assayed by preparing solutions of vesi-
cles containing biotin-dextran (10kD)-TAMRA. These vesicles were di-
luted to 1 mM lipid concentration and 10 μM Avidin-Alexaﬂuor488
was added to the solution. The samples were excited at 495 nm, the ex-
citation maximum for Alexaﬂuor488, and the emission was recorded at
588, close to the excitation maximum of TAMRA. The signal would only
be seen, therefore, if the biotin-dextran (10kD)-TAMRAmolecules were
close enough, or bound, to the Avidin-Alexaﬂuor488 to cause FRET.
Thus, FRET occurs only if one, or both, of the macromolecules can
cross the membrane. The background signal was recorded for about
50 s, at which time peptides were added to a ﬁnal ratio of 1:100 pep-
tide–lipid. The signal was then recorded until about 150 s, after which
time 10 μL of 10% Triton X-100 was added to fully lyse the vesicles.
The fractional leakage was analyzed using Eq. (3) as shown above.3. Results
3.1. Peptide design
The membrane interactions and folding of amphipathic α-helical
peptides are driven by partitioning into bilayers, due to hydrophobicity,
and by the coupling of partitioning and folding, due to amphipathicity
[24]. We have argued that the unique structural and functional proper-
ties of MelP5 are dominated by the nearly ideal amphipathic helix along
its length [12]. The pH-sensitive peptides GALA and pHLIP are likewise
hydrophobic sequences that are long enough to span a lipid bilayer
and fold into an α-helix. However, these peptides are prevented from
binding and folding, at neutral pH, by the fact that there aremultiple as-
partate or glutamate residues distributed along the putative hydropho-
bic helix. When fully charged, these acidic residues decrease the
interfacial hydrophobicity and disfavor folding due to repulsive interac-
tions in the putative helix. For both GALA and pHLIP, a decrease in pH
shifts the equilibrium toward the membrane-bound, α-helical state.
At a characteristic pH of 5–6, the free energy of partitioning and folding
can overcome the repulsion of the electrostatic groups and the peptide
will insert into bilayers and fold into helices.
Here we sought to engineer the same kind of pH sensitivity into an-
alogs of MelP5, while also preserving MelP5's unique pore-forming
properties. To do this, wemodiﬁed either 4 or 6 residues of MelP5 to as-
partate or glutamate as shown in Fig. 1. Our goalwas to create an appro-
priate arrangement of charges on the MelP5 backbone that was similar
to GALA and pHLIP. We applied several functional design principles.
First, and most importantly, we wished to maximize the number of i
to i + 3, i to i + 4, and i to i + 7 helical spacings tomaximize the pH sen-
sitivity of the helical secondary structure. Second, as in GALA, we
wanted the charged residues to bedistributed somewhat asymmetrical-
ly on the helical wheel and to overlap the polar face of MelP5, to pro-
mote pore formation. Third, we wanted the charges to be well
distributed along the helix length, but not on the helical ends where
the charge effects might be smaller. Fourth, we did not want the resi-
dues of MelP5 that were replaced with acidic residues to includemulti-
ple hydrophobic residues (leucine, isoleucine, and tryptophan) because
this would decrease the overall hydrophobicity andmembrane binding,
even at low pH. Indeed, a protonated or uncharged carboxyl group is
still polar and inserts somewhat unfavorably into membranes [24,25]).
Fifth, residues thought to be critical for the structure of MelP5
(e.g., Alal10,Pro14, and Ala23) were not altered. Using these principles,
we designed two sequences to test. MelP5_Δ4 has four substitutions
(V8, T11, S18, and K20 for glutamate or aspartate). This variant has 3
pairs of acidic residues that have helical spacings, and it only loses one
hydrophobic residue, valine 8. MelP5_Δ6 has 6 substitutions (the
same four as above, plus K7 and G12 for glutamate and aspartate).
This variant has six pairs of acidic residues with helical spacings. The
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signed peptide analogs are shown in Fig. 1.3.2. Binding and secondary structure formation
Wemonitored binding ofMelP5_Δ4 andMelP5_Δ6 to phosphatidyl-
choline vesicles as a function of pH using ﬂuorescence titration at vari-
ous pH values. Example spectra at pH 4 are shown in Fig. 2a and b.
Upon lipid titration, the tryptophan ﬂuorescence emission spectrum
shifts to shorter wavelengths and increases in intensity due to binding.
At higher lipid concentrations, intensities decrease due to light scatter-
ing, an effect that we correct for in the manner described in Materials
and Methods. Spectra are converted into binding isotherms as in
Fig. 2c, and from these curves, we obtain partition coefﬁcients Kx as de-
scribed elsewhere [26]. From Kx, we calculate ΔG= –RTln(Kx). The pH
dependence of the free energy of partitioning of MelP5_Δ4 and
MelP5_Δ6 are shown in Fig. 2d. At neutral pH, MelP5_Δ6 binds very
weakly to membranes, while MelP5_Δ4 binds measurably, consistent
with its more favorable overall hydrophobicity and fewer charge pairs
with helical spacing. As the pH is decreased, both peptides bind much
more strongly, such that by pH 4, both variants bind as well to bilayers
as MelP5, which binds very strongly to membranes [11,12]. The appar-
ent pKa values for the binding curves are about 4.6 forMelP5_Δ4 and 4.8
for MelP5_Δ6.
In order to determine if the peptides also acquired secondary struc-
ture in a pH-controlledmanner, circular dichroism spectrawere collect-
ed for these peptides in the presence of 1 mM POPC vesicles at various
pH values. Fig. 3a shows example CD spectra for MelP5_Δ4 and
MelP5_Δ6 at pH 7 and pH 4 in the presence of vesicles. The peptides
have random coil secondary structure at pH 7, as shown by the large
minimum at 200 nm, but become α-helical at pH 4, as shown by the
typical α-helix minima at 208 nm and 222 nm. In Fig. 3b, we show
the normalized α-helical content, calculated from the ellipticity atFig. 2. Peptide binding by tryptophan ﬂuorescence titration. This ﬁgure shows the results of bi
show tryptophan emission spectra after titration of 10 μM peptide with increasing amounts of
intensity (I/Io) at 335 nm, at pH 4, after correction for light scattering effects (see text). Data s
for each peptide/pH combination. Panel d shows the change in free energy of partitioning with222 nm, as a function of pH. These data follow the same trend with re-
spect to pH as the binding data shown in Fig. 2, demonstrating that
binding and structure formation are coupled. At a characteristic pH
value between 4.6 and 4.8, both peptides undergo cooperative structur-
al transitions from random coil to α-helix.
The helical content of the two analogs at low pH is roughly 50%,
which is only a little less than the helical content of melittin or MelP5
in membranes [11]. Taken together, binding and CD data show that
we have successfully engineered pH sensitivity into the sequence of
MelP5 and that the new peptides interact with membranes and fold
into α-helices at around pH 5, a range where useful biological activity
can be triggered.3.3. Pore-Forming Activity in Model Membranes
We performed vesicle leakage assays to characterize the membrane
activity and pore-forming properties of MelP5_Δ4 and MelP5_Δ6 as
functions of pH. First, we measured leakage of the small molecule
probes, ANTS/DPX,which are ~350Da each. As shown in Fig. 4 and else-
where [12], Melp5 is very potent and releases more than 50% of the
entrapped molecules at P:L ≥ 1:1000 at pH 7. The activity of MelP5 de-
creases slightly at pH4 for unknown reasons but it still shows high leak-
age at P:L ≥ 1:500. In contrast, at pH 7, MelP5_Δ4 and MelP5_Δ6 are
essentially inactive, even at P:L = 1:100, consistent with the fact that
they do not bind well and are not helical at pH 7. At pH 4, MelP5_Δ4
and MelP5_Δ6 are membrane active, causing signiﬁcant release of
ANTS/DPX at 1:100. However, their potency at pH 4 is somewhat less
than the potency of MelP5, causing less than 20% release at P:L= 1:500.
Lastly, we assessed the ability of the new peptides to release macro-
molecules from lipid vesicles. MelP5, as reported elsewhere [12], is
unique among pore-forming peptides in that it forms pores that enable
passage of macromolecules even at low P:L ratios (P:L ≤ 1:100). Here
we measured the release of a 10,000 Da dextran at P:L = 1:100 atnding experiments performed with the peptides MelP5_Δ4 and MelP5_Δ6. Panels a and b
POPC vesicles at pH 4. Panel c shows the lipid dependence of the change in ﬂuorescence
uch as those in panel c were ﬁt to Eq. (1) to obtain mole fraction partitioning coefﬁcients
respect to pH calculated using Eq. (2).
Fig. 3. Secondary structure ofMelP5_Δ4 andMelP5_Δ6. Left: The spectra of 100 μMMelP5_Δ4 andMelP5_Δ6 in the presence of 1mMPOPC lipid vesicles, at neutral pH and at acidic pH. At
pH 4, the spectra indicate α-helical structure, whereas at pH 7 the spectra are characteristic of random coil structure. Such measurements were carried out as a function of pH, and the
results are plotted in the right panel. The fraction helix is calculated from the ellipticity at 222 nm and is normalized to the maximal value, which is obtained at pH 4.
955G. Wiedman et al. / Biochimica et Biophysica Acta 1848 (2015) 951–957pH 4 and pH 7 using a FRET-based assay described in Materials and
Methods. In Fig. 5, we show that MelP5 releases nearly 100% of the dex-
tran molecules at both pH 4 and pH 7 when P:L = 1:100. Under theFig. 4. Small solute leakage. Leakage of ANTS and DPX from POPC vesicles wasmeasured after ad
containing entrapped ANTS and DPX were used. Leakage was determined from the increase in A
addition of the detergent TritonX-100, at the end of themeasurement. Thepairs of panels, one for
(left) and the fractional leakage caused by the peptides at the three P:L ratios, and at pH 4 and psame conditions, neither MelP5_Δ4 nor MelP5_Δ6 cause any measur-
able dextran release at either pH, despite the fact that they release
small molecules very efﬁciently at pH 4 and P:L = 1:100.dition of the peptidesMelP5, MelP5_Δ4, andMelP5_Δ6. In each case, 1 mMPOPC vesicles
NTS ﬂuorescence after peptide addition, relative to the increase in ANTS ﬂuorescence after
eachpeptide, showkinetic traces for leakage at pH4at P:L ratios of 1:100, 1:500, and 1:1000
H 7 (right). At 200 s, Triton X-100 was added to cause complete release.
Fig. 5.Macromolecular leakage. Panel a shows example FRET measurements of leakage caused by MelP5, MelP5_Δ4, and MelP5_Δ6. Lipid concentration was 1 mM and P:L was 1:100.
Excitation of Alexaﬂuor488-streptavidinwas at 495 nmand emission of biotin-dextran(10kD)-TAMRAwas at 588 nm. An increase in FRET indicates dextran leakage and complex formation.
At 150 s, Triton X-100 was added to completely permeabilize the vesicles. Panel b shows the fractional leakage of dextran at P:L = 1:100 for all three peptides at both pH 4 and pH 7.
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Here, we sought to engineer membrane-active peptides with new
activities by combining the properties of several well-understood
peptides. Speciﬁcally, we combined the properties of a unique
macromolecular-sized pore-forming peptide, MelP5, with those of two
pH-sensitive, membrane-active peptides, GALA and pHLIP. We hypoth-
esized that by replacing 4 or 6 carefully selected residues, out of 26, with
glutamate or aspartate, we could gain the ability to control peptide
activity, such that activity would occur only at acidic pH. Fluores-
cence-based binding assays and CD measurements demonstrated that
the analogs that we created do have pH-sensitive membrane binding
and secondary structure, with apparent pKa values between 4.6 and
5.0. The two analogs also caused bilayer permeabilization at low pH
but were inactive ay neutral pH. However, they did not possess the
unique ability of MelP5 to cause macromolecule-sized pores in
membranes.
Thus, thiswork shows that the properties ofMelP5, pHLIP, and GALA
are additive, but only partially so. Previously, it has been suggested
that the limitations in peptide engineering come from the lack of knowl-
edge of the molecular mechanism of action of membrane-active pep-
tides [10,27]. Here we demonstrate an additional roadblock: the lack
of additivity of membrane-active properties, even for very well-charac-
terized peptides.
Based on our ﬁndings, we propose that an approach based
on combinatorial chemistry and high-throughput screening [11,28]
may be the most efﬁcient way to engineer membrane-active peptides
with speciﬁc properties. This approach requires that a peptide library
is designed and then screened using high-throughput assays. The
approach has already yielded new peptides that can form large
equilibrium pores (both α-helical and β-sheet) [11], peptides that
translocate spontaneously across bilayers [29], and antimicrobial pep-
tides [28]. As the assays used here can be run in a high-throughput for-
mat, we are hopeful that peptides will eventually be identiﬁed that are
triggered by low pH to form macromolecular-sized pores in lipid
bilayers.Conﬂict of interest
The authors declare no conﬂict of interest.Acknowledg ments
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